Abstract
余家军, Liu Zhaokun, Chang Gao, Tongyue Yang, Zhen Ye, Junni Liu
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Aberrant pre-mRNA processing in cancer
10.1084/jem.20230891 · 2024
Steering research on mRNA splicing in cancer towards clinical translation
10.1038/s41568-024-00750-2 · 2024
The many roads from alternative splicing to cancer: Molecular mechanisms involving driver genes
10.3390/cancers16112123 · 2024
Nonsense-mediated mRNA decay: a key regulatory system engaged in cancer
10.1186/s12964-025-02503-6 · 2025
Insights into circular RNA biology
10.1080/15476286.2016.1271524 · 2017
Insights into the role of CircRNAs: Biogenesis, characterization, functional, and clinical impact in human Malignancies
10.3389/fcell.2021.617281 · 2021
The emerging roles and functions of circular RNAs and their generation
10.1186/s12929-019-0523-z · 2019
New insight into circRNAs: characterization, strategies, and biomedical applications
10.1186/s40164-023-00451-w · 2023
Emerging roles of CircRNA-miRNA networks in cancer development and therapeutic response
10.1016/j.ncrna.2024.09.006 · 2025
Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer
Provenance
crossref
Confidence 100%
ror
Confidence 99%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1038/s42003-024-07383-z · 2025
State-of-the-art strategies for circular RNA in cancers: Opportunity and challenge
10.1002/mco2.70608 · 2026
Circ_0089761 accelerates colorectal cancer metastasis and immune escape via miR-27b-3p/PD-L1 axis
10.14814/phy2.70137 · 2024
Toward precision oncology: deciphering the circRNA-EMT axis in cancer and its therapeutic implications
10.1080/15476286.2026.2639611 · 2026
Circular RNAs: Emerging regulators of signaling pathways in epithelial-mesenchymal transition and angiogenesis during breast cancer progression
10.1016/j.seminoncol.2025.152340 · 2025
Circular RNAs: key players in tumor immune evasion
10.1007/s11010-024-05186-8 · 2025
Novel insights into the role of circRNAs in cancer immunotherapy resistance and clinical implications
10.3390/ijms27083678 · 2026
CircRNAs in the tumor microenvironment: new frontiers in cancer progression and therapy
10.1016/j.critrevonc.2025.104754 · 2025
Molecular basis of backsplicing regulation and its application to manipulate circRNA levels
10.1080/15476286.2025.2525914 · 2025
The emerging roles of circRNAs in cancer and oncology
10.1038/s41571-021-00585-y · 2022
Complementary sequence-mediated exon circularization
10.1016/j.cell.2014.09.001 · 2014
EIciRNAs in focus: current understanding and future perspectives
10.1080/15476286.2024.2443876 · 2025
Systematic identification and characterization of exon-intron circRNAs
10.1101/gr.278590.123 · 2024
Intron lariat spliceosomes convert lariats to true circles: implications for intron transposition
10.1101/gad.351764.124 · 2024
Features and biomedical relevance of circular RNA biogenesis
10.1016/j.tig.2025.11.001 · 2026
Molecular mechanisms of circular RNA translation
10.1038/s12276-024-01220-3 · 2024
Circular RNAs acting as miRNAs' sponges and their roles in stem cells
10.3390/jcm11102909 · 2022
Circular RNA in cancer
10.1038/s41568-024-00721-7 · 2024
Going circular: history, present, and future of circRNAs in cancer
10.1038/s41388-023-02780-w · 2023
A length-dependent evolutionarily conserved pathway controls nuclear export of circular RNAs
10.1101/gad.314856.118 · 2018
Functional roles of conserved lncRNAs and circRNAs in eukaryotes
10.1016/j.ncrna.2024.06.014 · 2024
CircRNA in cancer: Fundamental mechanism and clinical potential
10.1016/j.canlet.2021.02.004 · 2021
Wet lab techniques for the functional analysis of circular RNA
10.3390/cells14231920 · 2025
CircAKT3 promotes prostate cancer proliferation and metastasis by enhancing the binding of RPS27A and RPL11
10.1186/s12943-025-02261-6 · 2025
CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K/AKT/mTOR activation
10.1186/s12943-024-02019-6 · 2024
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
10.1038/s41392-024-01955-5 · 2024
Unlocking the potential of extracellular vesicle circRNAs in breast cancer: From molecular mechanisms to therapeutic horizons
10.1016/j.biopha.2024.117480 · 2024
CircRNA ciRS-7: a novel oncogene in multiple cancers
10.7150/ijbs.54292 · 2021
Circular RNA CDR1as/ciRS-7- a novel biomarker in solid tumors
10.3389/fonc.2024.1468363 · 2024
Circ_CDR1as: a circular RNA with roles in the carcinogenesis
10.1016/j.prp.2022.153968 · 2022
CircRNA CDR1as/miR-7 signals promote tumor growth of osteosarcoma with a potential therapeutic and diagnostic value
10.2147/cmar.s178213 · 2018
Circular RNA vaccine in disease prevention and treatment
10.1038/s41392-023-01561-x · doi-reference
How laboratory guidelines promote the validity of circulating extracellular vesicle-associated nucleic acid biomarker signatures in liquid biopsy
10.3390/ijms262412115 · doi-reference
MIQE 2.0: Revision of the minimum information for publication of quantitative real-time PCR experiments guidelines
10.1093/clinchem/hvaf043 · doi-reference
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
10.1002/jev2.12404 · doi-reference
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides
10.1038/s41586-023-06834-7 · doi-reference
The circular RNA circFGFR4 facilitates resistance to anti-PD-1 of triple-negative breast cancer by targeting the miR-185-5p/CXCR4 axis
10.2147/cmar.s411901 · doi-reference
Synergistic immunoregulation: harnessing circRNAs and piRNAs to amplify PD-1/PD-L1 inhibition therapy
10.2147/ijn.s461289 · doi-reference
CircRNA knockout/knockdown tools in molecular biology research
10.1016/j.bbrc.2025.152607 · doi-reference
The potential role of exosomal circRNAs in the tumor microenvironment: insights into cancer diagnosis and therapy
10.7150/thno.64096 · doi-reference
Identification of circRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy
10.1038/s41467-023-38232-y · doi-reference
Circulating liquid biopsy biomarkers in glioblastoma: advances and challenges
10.3390/ijms25147974 · doi-reference
Optimized RNA-targeting CRISPR/Cas13d technology outperforms shRNA in identifying functional circRNAs
10.1186/s13059-021-02263-9 · doi-reference
Assessing the impacts of various factors on circular RNA reliability
10.26508/lsa.202201793 · doi-reference
Best practices to ensure robust investigation of circular RNAs: pitfalls and tips
10.15252/embr.202052072 · doi-reference
The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironment
10.1038/s41467-024-55577-0 · doi-reference
CircRUNX1 enhances the Warburg effect and immune evasion in non-small cell lung cancer through the miR-145/HK2 pathway
10.1016/j.canlet.2025.217639 · doi-reference
Circular RNA P4HB promotes glycolysis and tumor progression by binding with PKM2 in lung adenocarcinoma
10.1186/s12931-023-02563-7 · doi-reference
Lactate metabolic reprogramming mediated by circRNA-LDHA complex facilitates innate immune evasion of liver cancer
10.1002/advs.202509989 · doi-reference
The crosstalk and clinical implications of circRNAs and glucose metabolism in gastrointestinal cancers
10.3390/cancers15082229 · doi-reference
Exosomal Circsafb2 reshaping tumor environment to promote renal cell carcinoma progression by mediating M2 macrophage polarization
10.3389/fonc.2022.808888 · doi-reference
Hypoxic exosomal circPLEKHM1-mediated crosstalk between tumor cells and macrophages drives lung cancer metastasis
10.1002/advs.202309857 · doi-reference
CircNSD2 promotes metastasis and immune escape by increasing the USP10/SRSF6-mediated alternative splicing of TPM1 in TNBC
10.1186/s12943-026-02627-4 · doi-reference
Abstract P5-07-12: Circular RNA NCAPG promotes breast cancer metastasis through acting as the sponge of miR-200s
10.1158/1538-7445.sabcs18-p5-07-12 · doi-reference
Circular RNA hsa_circ_0067842 facilitates tumor metastasis and immune escape in breast cancer through HuR/CMTM6/PD-L1 axis
10.1186/s13062-023-00397-3 · doi-reference
The binding of PD-L1 and Akt facilitates glioma cell invasion upon starvation via Akt/Autophagy/F-Actin signaling
10.3389/fonc.2019.01347 · doi-reference
What role does PDL1 play in EMT changes in tumors and fibrosis
10.3389/fimmu.2023.1226038 · doi-reference
CircLRBA promotes epithelial-mesenchymal transition, immune evasion, chemoimmunotherapy resistance and metastasis through stabilizing Twist1
10.1002/advs.202508918 · doi-reference
Targeting the circC16orf62/miR-1299/PHF8 axis to suppress metastasis and overcome immune evasion in triple-negative breast cancer
10.1016/j.biopha.2026.119392 · doi-reference
Role of circular RNAs in regulating tumor microenvironment, epithelial mesenchymal transition, and resistance to cancer therapy
10.1016/j.critrevonc.2025.104942 · doi-reference
Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
10.1002/mco2.70019 · doi-reference
circ_0004140 promotes LUAD tumor progression and immune resistance through circ_0004140/miR-1184/CCL22 axis
10.1038/s41420-022-00983-w · doi-reference
Circular RNA circ_0020710 drives tumor progression and immune evasion by regulating the miR-370-3p/CXCL12 axis in melanoma
10.1186/s12943-020-01191-9 · doi-reference
Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells
10.1111/cas.15365 · doi-reference
Circular RNA CLASP1 modulates the GLI1/SNAIL axis and enhances macrophage polarization in breast cancer
10.1038/s41388-025-03627-2 · doi-reference
Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells
10.4049/jimmunol.177.2.896 · doi-reference
The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies
10.1080/08830185.2024.2401352 · doi-reference
Tumor cell-intrinsic circular RNA circFNDC3B attenuates CD8(+) T cells infiltration in non-small cell lung cancer
10.1038/s42003-025-08108-6 · doi-reference
Circular RNA circSnx5 controls immunogenicity of dendritic cells through the miR-544/SOCS1 axis and PU.1 activity regulation
10.1016/j.ymthe.2020.07.001 · doi-reference
Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma
10.1186/s12943-020-01222-5 · doi-reference
Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
10.1186/s12943-023-01759-1 · doi-reference